Susquehanna initiates coverage on Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) with a Positive rating. Price target $37.

Susquehanna analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE